Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-14, Stock:PFE, The news for the past five days is as follows:
2019-10-07: NEWS1: How A Deal With Pfizer Sent This Pharma Stock Rocketing In High Volume.NEWS2: Calithera (CALA) Completes Enrollment in Mid-Stage RCC Study.NEWS3: Zoetis Appoints Kristin Peck as New CEO, Alaix to Retire.NEWS4: Akcea Stocks Soars on Pfizer Licensing Agreement.NEWS5: Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx).
2019-10-08: NEWS1: Pfizer (PFE) Stock Moves -1.1%: What You Should Know.NEWS2: Were Hedge Funds Right About Souring on Pfizer?.NEWS3: 5 Underperforming Guru Stocks.NEWS4: Is Pfizer (NYSE:PFE) A Risky Investment?.NEWS5: REFILE-UPDATE 1-Humira, Rituxan top list of U.S. drugs with biggest price increases -report.NEWS6: REFILE-Humira, Rituxan top list of U.S. costliest drug price increases -report.
2019-10-09: NEWS1: Clovis (CLVS) Shares Drop on Goldman Sachs' Bearish Outlook.NEWS2: Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod & Other Updates.NEWS3: Nektar's Shares Drop on Rating Downgrade by Goldman Sachs.
2019-10-10: NEWS1: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.
2019-10-11: NEWS1: Startup with eye on fatty liver disease NASH lays out $70M IPO plan.NEWS2: Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals.NEWS3: Trader Toolkit: Cash Flow.

Answer: Rise